idside 0.1.0.dev0__py3-none-any.whl

This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
@@ -0,0 +1,350 @@
1
+ ID SIDE SOURCE-AVAILABLE LICENSE
2
+
3
+ Version 1.0 — 21 September 2026
4
+
5
+ Copyright 2026 ID side SAS (SIREN 848 377 644), France. All rights reserved.
6
+
7
+ Recitals
8
+ ========
9
+
10
+ This License governs use of the software made available by ID side SAS, a
11
+ company registered in France under SIREN 848 377 644 ("Licensor"), consisting
12
+ of the Consent SDK, its bindings, and accompanying documentation (the
13
+ "Software"). The Software is made available on a source-available basis and is
14
+ not distributed under an Open Source Initiative (OSI) approved open-source
15
+ license:
16
+
17
+ - you may read, evaluate, and use it under the terms below,
18
+
19
+ - certain uses, notably commercial purposes, require a separate paid
20
+ commercial license from Licensor.
21
+
22
+ 1. Definitions
23
+ ==============
24
+
25
+ "Software" means the Consent SDK source code, object code, associated
26
+ Documentation, bindings and any Modifications, in the form made available by
27
+ Licensor. A "Modification" is governed separately by this License and does not,
28
+ by itself, transfer ownership of Licensor's Intellectual Property.
29
+
30
+ "Documentation" means any technical specification, user manuals, or operational
31
+ guidelines Licensor provides describing the Software.
32
+
33
+ "You / Licensee" means the individual or legal entity exercising rights under
34
+ this License.
35
+
36
+ "Proof Object" means any cryptographically signed data object, token, or
37
+ payload generated by or derivedfrom the Software attesting to identity, legal
38
+ basis, consent, or authorization status.
39
+
40
+ "Affiliate" means, with respect to a party, any entity that directly or
41
+ indirectly controls, is controlled by, or is under common control with that
42
+ party, where "control" means ownership of more than 50% of the voting
43
+ securities or the power to direct management and policies, whether by contract
44
+ or otherwise.
45
+
46
+ "Production Deployment" means any use or installation of the Software (or any
47
+ Modification) that:
48
+
49
+ (a) Interacts with or provides services to any third party (including external
50
+ end-users, clients, or microservices); or
51
+
52
+ (b) Generates, issues, validates, or consumes Proof Objects outside Licensee’s
53
+ isolated, internal, non-production test environment.
54
+
55
+ "Commercial Purpose" means any use of the Software or any Modification other
56
+ than solely for non-production internal evaluation, research, development, and
57
+ non-commercial testing expressly permitted under Clause 2, including:
58
+
59
+ (a) any Production Deployment;
60
+
61
+ (b) any use of the Software or any Modification to generate, issue, validate,
62
+ consume, or rely upon a Proof Object in a production or live environment,
63
+ including any production key request or other non-sandbox execution;
64
+
65
+ (c) any provision of the Software, any Modification, or functionality
66
+ materially derived from the Software to or for the benefit of any third
67
+ party, whether a fee is charged or not; or
68
+
69
+ (d) any Competing Use.
70
+
71
+ For the avoidance of doubt, a use may constitute a Commercial Purpose
72
+ regardless of whether the Licensee or any third party receives monetary
73
+ consideration, and regardless of the Licensee's corporate structure, revenue,
74
+ employee count, or subjective intent. Use solely within an isolated,
75
+ non-production environment for internal evaluation, research, development, or
76
+ testing does not constitute a Commercial Purpose, provided that such use does
77
+ not constitute a Competing Use
78
+
79
+ "Competing Use" means using the Software, any Modification, or any Confidential
80
+ information derived from Licensee's access to the Software to build, offer,
81
+ license, or support a product, service, or component that (i) would, if made,
82
+ used, sold, offered for sale, or imported without a license, infringe any claim
83
+ of a Licensor Patent, or (ii) implements the specific consent-signal
84
+ architecture disclosed in the Software or Documentation (namely,
85
+ cryptographically-verifiable, third-party-issued proof objects mediating
86
+ personal-data-processing choices between a client system and a remote system).
87
+ Competing Use does not include developing products or services that fall
88
+ outside the scope of the Licensor Patents and do not implement the specific
89
+ architecture described above -even where such products address a similar
90
+ business problem or appear on Licensor's current or future public product
91
+ roadmap.
92
+
93
+ "Modification" means any revision, adaptation, translation, binding, or
94
+ derivative work of the Software prepared by or for Licensee.
95
+
96
+ "Licensor Patents" means (i) U.S. Patent No. 12,413,397 B2; (ii) European
97
+ Patent No. 4,100,905 B1 and any national patent rights deriving from that
98
+ European patent; and (iii) Chinese Patent Application No. CN115151937A and any
99
+ patent issuing therefrom; and (iv) any other patent application now or
100
+ hereafter owned or controlled by Licensor and covering the Software or its use,
101
+ together with any patent that issues, and any continuation, divisional,
102
+ reissue, continuation-in-part, reexamination, or foreign counterpart of any
103
+ patent or application identified in (i) through (iv), in each case to the
104
+ extent owned or controlled by Licensor and covering the Software or its use.
105
+ Licensee acknowledges that patent applications identified above are pending and
106
+ not yet issued, that no patent rights exist in an application prior to
107
+ issuance, and that this License does not represent or warrant the scope,
108
+ validity, or ultimate issuance of any pending application.
109
+
110
+ 2. Grant: Evaluation and Internal Non-Production Use
111
+ ====================================================
112
+
113
+ Subject to Licensee's strict compliance with this License, Licensor grants
114
+ Licensee a worldwide, royalty-free, non-exclusive, non-transferable, revocable
115
+ copyright license to reproduce, display, execute, and modify the Software
116
+ solely for non-production internal evaluation, research, and non-commercial
117
+ testing. Licensor also grants, for the same limited purpose and duration, a
118
+ non-exclusive, royalty-free patent license under the Licensor Patents solely to
119
+ make, use, execute, test, and modify the Software as permitted under this
120
+ Clause 2. No patent license is granted for production, distribution, offering
121
+ for sale, sale, importation, or other commercial exploitation.
122
+
123
+ Licensee may not redistribute, sub-license, host as a managed service, or make
124
+ available the Software or any Modification to any third party without
125
+ Licensor's express prior written consent.
126
+
127
+ Nothing in this License restricts any act of decompilation or reverse
128
+ engineering that is permitted on a non-waivable basis under Article 6 of
129
+ Directive (EU) 2009/24 (or successor legislation) or an equivalent mandatory
130
+ provision of applicable law, including for the purpose of achieving
131
+ interoperability of an independently created program. Outside the scope of such
132
+ mandatory rights, Licensee shall not decompile, disassemble, or reverse
133
+ engineer the Software except to the extent permitted by applicable law
134
+ notwithstanding this restriction.
135
+
136
+ If Licensee provides Licensor with any suggestion, comment, or other feedback
137
+ regarding the Software during its evaluation, Licensee grants Licensor a
138
+ perpetual, irrevocable, worldwide, royalty-free license to use, disclose, and
139
+ incorporate that feedback into the Software or any other Licensor product or
140
+ service, without restriction or obligation to Licensee.
141
+
142
+ 3. Commercial Use Requires a Separate Commercial License
143
+ ========================================================
144
+
145
+ Any use of the Software or generation/validation of Proof Objects for a
146
+ Commercial Purpose is strictly outside the scope of Clause 2.
147
+
148
+ Commercial Purpose use requires an executed, paid Commercial License Agreement
149
+ directly with Licensor under Licensor’s standard commercial terms.
150
+
151
+ Any use for a Commercial Purpose without a valid Commercial License in force
152
+ may constitute copyright infringement and/or patent infringement, as applicable
153
+ under the law governing the relevant right and activity.
154
+
155
+ 4. Operational & Intellectual Property Restrictions
156
+ ===================================================
157
+
158
+ Licensee shall not, directly or indirectly:
159
+
160
+ (a) remove obscure, or alter any copyright, patent, trademark, or proprietary
161
+ rights notices contained in or on the Software;
162
+
163
+ (b) use Licensor's name, logos, or trademarks except as required to provide
164
+ accurate attribution of software origin;
165
+
166
+ (c) circumvent, disable, bypass, or tamper with any licensing check, telemetry,
167
+ key verification, or cryptographic signing mechanism in the Software; or
168
+
169
+ (d) represent any Modification as an official release of Licensor;
170
+
171
+ (e) validate or accept in a commercial environment any Proof Object created by
172
+ an unlicensed instance of the Software;
173
+
174
+ (f) use the Software or any output of the Software in violation of applicable
175
+ export control or economic sanctions laws, including those of the United
176
+ States, the European Union, and France, and Licensee represents that it is
177
+ not located in, under the control of, or a national or resident of any
178
+ country or party subject to a comprehensive embargo under such laws;
179
+
180
+ (g) reproduce, publish, or otherwise make available any patent notice embedded
181
+ in the Software's source code or Documentation in a manner that omits or
182
+ obscures the Licensor Patents identification required under Clause 5.
183
+
184
+ 5. Patent Provisions & Defensive Protection
185
+ ===========================================
186
+
187
+ No Implied Patent License: Except for the limited evaluation patent license
188
+ expressly granted in Clause 2, no license or immunity under any Licensor
189
+ Patents is granted, implied, or created by estoppel. Making the Software
190
+ available on a source-available basis does not constitute a waiver of any of
191
+ Licensor's patent rights.
192
+
193
+ Commercial Patent Grant: A limited, non-exclusive patent license under the
194
+ Licensor Patents shall be conveyed solely through an executed Commercial
195
+ License Agreement under Clause 3. The Commercial License Agreement should
196
+ expressly define the licensed territory, term, permitted acts (including, as
197
+ applicable, making, having made, using, offering for sale, selling, importing,
198
+ distributing, and/or otherwise exploiting the Software), and any field-of-use
199
+ or deployment restrictions.
200
+
201
+ Patent Non-Assert by Licensee: In consideration for the evaluation rights
202
+ granted under Clause 2, Licensee covenants that it shall not assert any patent
203
+ owned or controlled by Licensee against Licensor or its affiliates solely on
204
+ the basis that the permitted use, execution, modification, or interfacing of
205
+ the Software practices such patent, except for claims arising from Licensor's
206
+ material breach of an express patent grant or from infringement unrelated to
207
+ the Software.
208
+
209
+ Defensive Termination: If Licensee or its affiliates initiates or voluntarily
210
+ assists a proceeding asserting that the Software or a Licensor product
211
+ infringes a patent or other intellectual property right owned or controlled by
212
+ Licensee, Licensor may terminate the rights granted under this License, subject
213
+ to any mandatory applicable law and without prejudice to accrued rights. A bona
214
+ fide third-party infringement claim or regulatory proceeding not initiated or
215
+ voluntarily assisted by Licensee shall not, by itself, trigger this provision.
216
+
217
+ Validity Challenge Termination: If Licensee or its Affiliates files, joins,
218
+ funds, or voluntarily and materially assists any proceeding challenging the
219
+ validity, enforceability, patentability, or scope of any Licensor Patent
220
+ (including an inter partes review (IPR), post-grant review, ex parte or inter
221
+ partes reexamination, opposition, nullity action, or invalidity counterclaim or
222
+ defense asserted otherwise than as a compulsory response to an infringement
223
+ claim first brought by Licensor against that Licensee), Licensor may terminate
224
+ the rights granted under this License upon written notice, without prejudice to
225
+ any other right or remedy.
226
+
227
+ Notice - Patent Marking: Licensee acknowledges that access to the Software
228
+ under this License, including the identification of the Licensor Patents in
229
+ Clause 1, constitutes actual notice of the Licensor Patents within the meaning
230
+ of 35 U.S.C. §287(a) and any analogous notice provision of applicable law,
231
+ effective as of the date Licensee first accesses the Software. Licensor may
232
+ include a notice identifying the Licensor Patents in the Software's source
233
+ code, object code, and Documentation, and Licensee shall not remove or obscure
234
+ such notice.
235
+
236
+ 6. Term and Termination
237
+ =======================
238
+
239
+ This License remains in effect until terminated. It terminates automatically
240
+ without notice if Licensee materially breaches any provision and, where the
241
+ breach is capable of cure, fails to cure it within ten (10) business days after
242
+ written notice.
243
+
244
+ Upon termination, Licensee must cease all use, deployment, and distribution of
245
+ the Software and, subject to applicable law and any surviving rights expressly
246
+ granted in a Commercial License, destroy all copies of the Software and
247
+ Modifications in its possession. Clauses 3, 4, 5, 7, 8, 9, and 10 shall survive
248
+ termination.
249
+
250
+ 7. Assignment: Change of Control
251
+ ================================
252
+
253
+ This License and the rights granted under Clause 2 are personal to Licensee and
254
+ may not be assigned, transferred, or sublicensed, whether by operation of law,
255
+ merger, or otherwise, without Licensor's prior written consent, which may be
256
+ withheld in Licensor's sole discretion where the proposed assignee is a direct
257
+ competitor of Licensor or a party against whom Licensor has an active or
258
+ reasonably anticipated intellectual property dispute involving the Software or
259
+ the Licensor Patents. Any Change of Control of Licensee shall be treated as an
260
+ assignment for purposes of this Clause ("Change of Control" means any
261
+ transaction or series of related transactions resulting in a person or entity
262
+ that did not previously control Licensee -within the meaning given to "control"
263
+ in the definition of Affiliate- acquiring such control). Licensor may terminate
264
+ this License upon written notice following a Change of Control to which it has
265
+ not consented.
266
+
267
+ 8. Audit and Compliance Verification
268
+ ====================================
269
+
270
+ Licensor may, upon no less than fifteen (15) business days' prior written
271
+ notice and no more than once in any twelve (12)-month period (or at any time if
272
+ Licensor reasonably believes a breach has occurred), request that Licensee
273
+ provide reasonable written confirmation and supporting records sufficient to
274
+ verify Licensee's compliance with the scope of use permitted under Clause 2,
275
+ including the environments in which the Software has been deployed and whether
276
+ any Production Deployment has occurred. Licensee shall respond within fifteen
277
+ (15) business days. Nothing in this Clause obligates Licensee to disclose
278
+ source code, trade secrets, or information protected by attorney-client
279
+ privilege beyond what is reasonably necessary to confirm compliance.
280
+
281
+ 9. Data Protection
282
+ ==================
283
+
284
+ The Software may be used by Licensee to process personal data, including in
285
+ connection with the generation, issuance, validation, or consumption of Proof
286
+ Objects. As between the parties, Licensee is solely responsible, as data
287
+ controller or processor as applicable, for ensuring that its use of the
288
+ Software complies with the GDPR and any other applicable data protection law.
289
+ Nothing in this License constitutes a data processing agreement under Article
290
+ 28 GDPR, and Licensor acts under this License solely as a supplier of software,
291
+ not as a processor nor joint controller of any personal data processed by
292
+ Licensee's use of the Software.
293
+
294
+ 10. Disclaimer of Warranty
295
+ ==========================
296
+
297
+ THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
298
+ IMPLIED, INCLUDING BUT NOT LIMITED TO WARRANTIES OF MERCHANTABILITY, FITNESS
299
+ FOR A PARTICULAR PURPOSE, TITLE, AND NON-INFRINGEMENT. LICENSOR DOES NOT
300
+ WARRANT THAT THE SOFTWARE OR ANY PROOF OBJECT GENERATED THEREBY WILL MEET
301
+ REGULATORY, STATUTORY, OR LEGAL COMPLIANCE OBLIGATIONS IN ANY JURISDICTION.
302
+
303
+ 11. Limitation of Liability
304
+ ===========================
305
+
306
+ TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL LICENSOR
307
+ BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL, CONSEQUENTIAL, OR PUNITIVE
308
+ DAMAGES, OR FOR LOSS OF PROFITS, DATA, OR GOODWILL, ARISING OUT OF OR IN
309
+ CONNECTION WITH THIS LICENSE OR THE USE OF THE SOFTWARE, EVEN IF ADVISED OF THE
310
+ POSSIBILITY OF SUCH DAMAGES.
311
+
312
+ 12. Governing Law and Jurisdiction
313
+ ==================================
314
+
315
+ Governing Law: This License shall be governed by and construed in accordance
316
+ with the laws of France, without regard to its conflict-of-law principles. The
317
+ UN Convention on Contracts for the International Sale of Goods (CISG) shall not
318
+ apply.
319
+
320
+ Dispute Resolution: Any dispute arising out of or in connection with this
321
+ License, other than a claim for injunctive relief or a claim to enforce a
322
+ Licensor Patent as set out below, shall be finally settled under the Rules of
323
+ Arbitration of the International Chamber of Commerce by one arbitrator
324
+ appointed in accordance with those Rules. The seat of arbitration shall be
325
+ Paris, France, and the language of the arbitration shall be English.
326
+ Notwithstanding the foregoing, either party may seek interim or provisional
327
+ relief, including injunctive relief, from any court of competent jurisdiction.
328
+
329
+ Injunctions & Patent Carve-Out: Notwithstanding the foregoing, Licensor retains
330
+ the right to seek injunctive or other appropriate relief, and to enforce the
331
+ Licensor Patents, before any competent court or tribunal in a jurisdiction
332
+ where the relevant patent is in force and the relevant infringement occurs or
333
+ threatens to occur, including, as applicable, United States federal courts,
334
+ competent national courts in Europe, and the Unified Patent Court where it has
335
+ jurisdiction. Nothing in this Clause expands the territorial scope or validity
336
+ of any Licensor Patent.
337
+
338
+ 10. General Terms
339
+ =================
340
+
341
+ This License constitutes the entire evaluation agreement between Licensor and
342
+ Licensee regarding the Software. In the event of a conflict between this
343
+ License and a separately executed Commercial License Agreement, the Commercial
344
+ License Agreement shall govern. If any provision of this License is found
345
+ invalid, the remaining provisions shall remain fully enforceable.
346
+
347
+ Licensor retains all right, title, and interest in and to the Software and all
348
+ Intellectual Property Rights therein, including the Licensor Patents. No rights
349
+ are granted by implication, and this License does not transfer any ownership
350
+ interest in the Software.
@@ -0,0 +1,29 @@
1
+ ID Side SDK
2
+ Copyright 2026 ID side SAS. All rights reserved.
3
+
4
+ This product includes software developed at ID Side (https://idside.eu).
5
+
6
+ PATENTS
7
+ =======
8
+
9
+ Patents: https://sdk.idside.eu/patents
10
+
11
+ This software may be covered by:
12
+
13
+ - U.S. Patent No. 12,413,397 B2;
14
+ - European Patent No. 4,100,905 B1, with unitary effect, and any national
15
+ patent rights deriving from that European patent;
16
+ - Chinese Patent Application No. CN115151937A (pending; no patent rights
17
+ exist in an application before it issues).
18
+
19
+ The page above lists them and is kept current. It is the notice that clause 5
20
+ of LICENSE provides for; clauses 4(a) and 4(g) of LICENSE forbid removing or
21
+ obscuring it, or reproducing it with the patents left out.
22
+
23
+ Beyond the limited evaluation patent licence of clause 2 of LICENSE, rights
24
+ under these patents are conveyed only by an executed commercial licence from
25
+ ID Side.
26
+
27
+ Publishing the ACT token format so that anyone can verify a token is a
28
+ different act from licensing the invention that produces one, and the two are
29
+ kept apart deliberately: a proof nobody outside can check is not a proof.